IP Library Granted Patent US 7,071,306
Granted Patent B2
US 7,071,306 · App. 10/121,675 · Granted Jul 4, 2006

AMPA-binding human GluR4 receptors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,071,306
App. No.
10/121,675
Granted
Jul 4, 2006
Kind
B2
Abstract

Described herein are isolated polynucleotides which code for an AMPA-type human CNS receptor, designated the human GluR4B receptor. The receptor is characterized structurally and the construction and use of cell lines expressing the receptor is disclosed.

Claims (8)

1. A human GluR4B receptor, in a form essentially free from other proteins of human origin.

2. An AMPA-binding fragment of the human GluR4B receptor.

3. An immunogenic fragment of a human GluR4B receptor that generates antibodies specific to a GluR4B receptor.

4. A human GluR4B receptor of SEQ ID NO. 2 in a form essentially free from other proteins of human origin.

5. An AMPA-binding fragment of the polypeptide claim 4 .

6. An immunogenic fragment of the polypeptide of claim 4 that generates antibodies specific to a GluR4B receptor.

7. A process for obtaining a substantially homogeneous source of a human EAA receptor which comprises the steps of culturing a cellular host transformed with a vector comprising a polynucleotide comprising nucleic acids arranged in a sequence that encodes the human GluR4B receptor, and then recovering the cultured cells.

8. A process for obtaining a substantially homogeneous source of a human EAA receptor according to claim 7 , comprising the subsequent step of obtaining a membrane preparation from the cultured cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2008
From: NPS ALLELIX CORP.
To: NPS PHARMACEUTICALS, INC.
Reel/Frame 021339/0977 →